About SafeStitch Medical (NYSEAMERICAN:TRXC)
TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:TRXC
CUSIPN/A
Phone+1-919-7658400
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-21,045.36%
Return on Equity-137.69%
Return on Assets-83.60%
Miscellaneous
EmployeesN/A
Outstanding Shares201,970,000
SafeStitch Medical (NYSEAMERICAN:TRXC) Frequently Asked Questions
What is SafeStitch Medical's stock symbol?
SafeStitch Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "TRXC."
How were SafeStitch Medical's earnings last quarter?
SafeStitch Medical Inc. (NYSEAMERICAN:TRXC) posted its earnings results on Tuesday, March, 6th. The medical instruments supplier reported ($0.40) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.34. The medical instruments supplier earned $3.40 million during the quarter, compared to the consensus estimate of $3.46 million. SafeStitch Medical had a negative net margin of 21,045.36% and a negative return on equity of 137.69%. View SafeStitch Medical's Earnings History.
What price target have analysts set for TRXC?
4 Wall Street analysts have issued 1-year price objectives for SafeStitch Medical's stock. Their predictions range from $0.70 to $5.00. On average, they anticipate SafeStitch Medical's share price to reach $3.2333 in the next year. View Analyst Ratings for SafeStitch Medical.
Are investors shorting SafeStitch Medical?
SafeStitch Medical saw a increase in short interest in the month of March. As of March 29th, there was short interest totalling 22,500,530 shares, an increase of 3.4% from the March 15th total of 21,769,028 shares. Based on an average daily trading volume, of 1,700,557 shares, the days-to-cover ratio is presently 13.2 days. Approximately 15.2% of the company's shares are sold short.
Who are some of SafeStitch Medical's key competitors?
Some companies that are related to SafeStitch Medical include Dova Pharmaceuticals (DOVA), Triple-S Management (GTS), AMAG Pharmaceuticals (AMAG), Rocket Pharmaceuticals (RCKT), Anika Therapeutics (ANIK), RadNet (RDNT), Endocyte (ECYT), Novavax (NVAX), New England Nuclear (LNTH), STAAR Surgical (STAA), Hanger (HNGR), Jounce Therapeutics (JNCE), Mesa Laboratories (MLAB), Addus HomeCare (ADUS), Tactile Systems Technology (TCMD), Lannett (LCI), Reata Pharmaceuticals (RETA) and Meridian Bioscience (VIVO).
Who are SafeStitch Medical's key executives?
SafeStitch Medical's management team includes the folowing people:
- Mr. Todd M. Pope, CEO, Pres & Director (Age 53)
- Mr. Joseph P. Slattery, Exec. VP, CFO & Principal Accounting Officer (Age 53)
- Mr. Anthony Fernando, COO, CTO & Exec. VP (Age 46)
- Mr. Joshua B. Weingard, Chief Legal Officer & Sec. (Age 45)
- Dr. Stephanie M. Fitts Ph.D., VP of RA/QA, Clinical and Compliance (Age 52)
Has SafeStitch Medical been receiving favorable news coverage?
Media coverage about TRXC stock has trended somewhat positive this week, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. SafeStitch Medical earned a news sentiment score of 0.18 on Accern's scale. They also gave headlines about the medical instruments supplier an impact score of 47.19 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near future.
How do I buy shares of SafeStitch Medical?
Shares of TRXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is SafeStitch Medical's stock price today?
One share of TRXC stock can currently be purchased for approximately $1.90.
How big of a company is SafeStitch Medical?
SafeStitch Medical has a market capitalization of $354.65 million.
How can I contact SafeStitch Medical?
SafeStitch Medical's mailing address is 635 Davis Dr Ste 300, MORRISVILLE, NC 27560-7199, United States. The medical instruments supplier can be reached via phone at +1-919-7658400.
MarketBeat Community Rating for SafeStitch Medical (TRXC)
MarketBeat's community ratings are surveys of what our community members think about SafeStitch Medical and other stocks. Vote "Outperform" if you believe TRXC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRXC will underperform the S&P 500 over the long term. You may vote once every thirty days.
SafeStitch Medical (NYSEAMERICAN:TRXC) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
4 Wall Street analysts have issued ratings and price targets for SafeStitch Medical in the last 12 months. Their average twelve-month price target is $3.2333, suggesting that the stock has a possible upside of 70.18%. The high price target for TRXC is $5.00 and the low price target for TRXC is $0.70. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.50 | 2.50 | 2.50 | 2.50 |
| Ratings Breakdown: | 0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $3.2333 | $3.2333 | $3.2333 | $2.85 |
| Price Target Upside: | 70.18% upside | 39.97% upside | 39.97% upside | 7.47% downside |
SafeStitch Medical (NYSEAMERICAN:TRXC) Consensus Price Target History
SafeStitch Medical (NYSEAMERICAN:TRXC) Analyst Ratings History
Show:
(Data available from 4/22/2016 forward)
SafeStitch Medical (NYSEAMERICAN:TRXC) Earnings History and Estimates Chart
SafeStitch Medical (NYSEAMERICAN TRXC) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 3/6/2018 | Q4 2017 | ($0.06) | ($0.40) | $3.46 million | $3.40 million | View | N/A |  |
| 11/9/2017 | Q3 2017 | ($0.09) | ($0.09) | $0.01 million | $0.18 million | View | N/A | |
| 8/2/2017 | Q2 2017 | ($0.11) | ($0.11) | $0.87 million | $1.58 million | View | N/A | |
| 5/10/2017 | Q1 2017 | ($0.12) | ($0.13) | $1.72 million | $1.95 million | View | N/A | |
| 3/6/2017 | Q4 2016 | ($0.11) | ($0.12) | $0.91 million | $0.05 million | View | Listen | |
| 11/9/2016 | Q316 | ($0.10) | ($0.11) | $1.80 million | $1.50 million | View | Listen | |
| 8/5/2016 | Q2 2016 | ($0.13) | ($0.11) | | | View | N/A | |
| 5/10/2016 | Q116 | ($0.13) | ($0.12) | | | View | Listen | |
| 3/3/2016 | Q415 | ($0.12) | ($0.13) | | | View | N/A | |
| 11/9/2015 | Q3 2015 | ($0.11) | ($0.11) | | | View | N/A | |
| 8/6/2015 | Q215 | ($0.15) | ($0.14) | | | View | N/A | |
| 5/6/2015 | Q115 | ($0.17) | ($0.16) | $0.03 million | | View | N/A | |
| 2/24/2015 | Q414 | ($0.18) | ($0.13) | $50.00 million | $0.13 million | View | N/A | |
| 11/6/2014 | Q3 | ($0.18) | ($0.18) | $0.10 million | $0.06 million | View | N/A | |
| 8/6/2014 | Q2 2014 | ($0.13) | ($0.18) | $0.09 million | $0.11 million | View | N/A | |
| 5/7/2014 | | ($0.14) | ($0.15) | $0.20 million | $0.09 million | View | N/A | |
| 3/5/2014 | Q4 2013 | | ($0.20) | | $0.22 million | View | N/A | |
| 11/12/2013 | Q3 2013 | | ($0.60) | | $0.36 million | View | N/A | |
| 8/14/2013 | Q2 2013 | | ($0.10) | | $0.01 million | View | N/A | |
| 5/15/2013 | Q1 2013 | | ($0.05) | | $0.01 million | View | N/A | |
| 4/1/2013 | Q4 2012 | | ($0.15) | | | View | N/A | |
| 11/14/2012 | Q3 2012 | | ($0.15) | | | View | N/A | |
| 8/14/2012 | Q2 2012 | | ($0.20) | | | View | N/A | |
| 5/15/2012 | Q1 2012 | | ($0.28) | | | View | N/A | |
| 3/30/2012 | Q4 2011 | | ($0.28) | | | View | N/A | |
| 11/14/2011 | Q3 2011 | | ($0.27) | | | View | N/A | |
| 8/12/2011 | Q2 2011 | | ($0.24) | | | View | N/A | |
| 5/16/2011 | Q1 2011 | | ($0.24) | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
SafeStitch Medical (NYSEAMERICAN:TRXC) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
SafeStitch Medical (NYSEAMERICAN TRXC) Insider Trading and Institutional Ownership History
SafeStitch Medical (NYSEAMERICAN TRXC) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/16/2017 | Joseph P Slattery | CFO | Sell | 529,609 | $2.80 | $1,482,905.20 | 440,974 | |
| 11/14/2017 | Joseph P Slattery | CFO | Sell | 333,000 | $2.93 | $975,690.00 | 440,974 | |
| 10/18/2017 | Todd Pope | Insider | Sell | 600,000 | $3.68 | $2,208,000.00 | 462,644 | |
| 8/8/2017 | Willam N Kelley | Director | Buy | 30,000 | $0.71 | $21,300.00 | | |
| 5/16/2017 | Richard C Pfenniger Jr | Director | Buy | 100,000 | $0.54 | $54,000.00 | 148,000 | |
| 1/4/2017 | S.P.A Sofar | Major Shareholder | Buy | 3,722,685 | $1.40 | $5,211,759.00 | 19,266,098 | |
| 8/22/2016 | Andrea Biffi | Director | Buy | 40,000 | $1.40 | $56,000.00 | 90,000 | |
| 6/14/2016 | Anthony C J Fernando | CTO | Buy | 27,000 | $1.46 | $39,420.00 | 27,000 | |
| 5/13/2016 | Joseph P Slattery | CFO | Buy | 50,000 | $1.92 | $96,000.00 | 172,387 | |
| 11/16/2015 | Andrea Biffi | Director | Buy | 25,000 | $2.81 | $70,250.00 | 50,000 | |
| 11/13/2015 | Willam N Kelley | Director | Buy | 20,000 | $2.80 | $56,000.00 | | |
| 11/12/2015 | Joseph P Slattery | CFO | Buy | 15,000 | $2.77 | $41,550.00 | 135,087 | |
| 10/2/2014 | Joseph P Slattery | CFO | Sell | 33,000 | $4.19 | $138,270.00 | | |
| 9/8/2014 | Richard Mueller | COO | Sell | 3,000 | $3.60 | $10,800.00 | | |
| 9/8/2014 | Todd Pope | CEO | Sell | 50,000 | $3.70 | $185,000.00 | | |
| 4/21/2014 | Aisling Capital Iii Lp | Major Shareholder | Buy | 1,037,767 | $4.00 | $4,151,068.00 | | |
| 4/21/2014 | William N Starling Jr | Director | Buy | 221,450 | $4.00 | $885,800.00 | | |
(Data available from 1/1/2013 forward)
SafeStitch Medical (NYSEAMERICAN TRXC) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | SafeStitch Medical (TRXC) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - April 18 at 2:58 PM |
 | Is There Now An Opportunity In TransEnterix Inc (NYSEMKT:TRXC)?
finance.yahoo.com - April 14 at 8:12 AM |
| SafeStitch Medical Inc. (TRXC) Short Interest Up 3.4% in March
www.americanbankingnews.com - April 10 at 6:56 PM |
| Why TransEnterix Fell 10.5% in March
finance.yahoo.com - April 5 at 5:25 PM |
| Transenterix (TRXC) PT Raised to $4.00
www.americanbankingnews.com - April 3 at 9:54 PM |
| Transenterix Inc (TRXC) Sees Large Increase in Short Interest
www.americanbankingnews.com - March 26 at 6:32 PM |
| Transenterix Inc (TRXC) Short Interest Up 14.9% in February
www.americanbankingnews.com - March 9 at 6:02 PM |
| Transenterix (TRXC) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - March 8 at 7:03 PM |
| TransEnterix Management Talks Growth, Product Enhancements, Financing, and More
finance.yahoo.com - March 8 at 6:56 PM |
 | Transenterix (NYSE:TRXC) - TransEnterix Q4 Earnings Preview ... - Benzinga
www.benzinga.com - March 7 at 8:09 AM |
| TransEnterix Q4 Earnings Preview
finance.yahoo.com - March 6 at 5:47 PM |
| TransEnterix, Inc. to Host Earnings Call
finance.yahoo.com - March 6 at 5:47 PM |
| TransEnterix, Inc. Reports Operating Results for the Fourth Quarter and Full Year 2017
finance.yahoo.com - March 6 at 5:47 PM |
| Transenterix Inc (TRXC) Reports Results for 2017 4Q and Full Year
finance.yahoo.com - March 6 at 5:47 PM |
| EAM Investors LLC Invests $1.33 Million in Transenterix Inc (TRXC)
www.americanbankingnews.com - March 3 at 5:40 AM |
| Transenterix Inc (TRXC) Short Interest Update
www.americanbankingnews.com - February 27 at 5:40 PM |
 | What's Pushing Up TransEnterix Inc. Stock Today? - Motley Fool
www.fool.com - February 27 at 8:09 AM |
 | What's Pushing Up TransEnterix Inc. Stock Today?
www.msn.com - February 26 at 5:51 PM |
| What's Pushing Up TransEnterix Inc. Stock Today?
finance.yahoo.com - February 26 at 5:51 PM |
| Why TransEnterix Is Rising Today
finance.yahoo.com - February 21 at 5:33 PM |
| New Research: Key Drivers of Growth for Stag Industrial, Heartland Express, Antero Midstream Partners LP, TransEnterix, A-Mark Precious Metals, and Franklin Street Properties — Factors of Influence, Major Initiatives and Sustained Production
finance.yahoo.com - February 20 at 8:10 AM |
| TransEnterix Announces FDA 510(k) Submission for Senhance Indication Expansion to More than Double Addressable Market in the U.S. and Provides Commercial Update
finance.yahoo.com - February 14 at 8:49 AM |
| TransEnterix to Present at the RBC Capital Markets 2018 Global Healthcare Conference
finance.yahoo.com - February 7 at 8:31 AM |
| TransEnterix to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
finance.yahoo.com - January 31 at 8:43 AM |
 | This Morning's Technical Outlook on Medical Supplies Stocks -- TransEnterix, Akers Biosciences, Antares Pharma, and Microbot Medical
www.prnewswire.com - January 30 at 8:32 AM |
| Short Interest in Transenterix Inc (TRXC) Increases By 6.4%
www.americanbankingnews.com - January 24 at 5:40 PM |
| Transenterix (TRXC) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - January 23 at 6:08 PM |
| Edited Transcript of TRXC earnings conference call or presentation 10-May-17 8:30pm GMT
finance.yahoo.com - January 18 at 3:33 PM |
| Transenterix Inc (TRXC) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - January 13 at 4:01 AM |
| Transenterix (TRXC) Downgraded by Zacks Investment Research to Sell
www.americanbankingnews.com - January 11 at 3:32 PM |
| Here's Why TransEnterix Rallied 47% in 2017
finance.yahoo.com - January 9 at 4:11 PM |
 | TransEnterix (TRXC) Announces 2017 Year-End Corporate Update - StreetInsider.com
www.streetinsider.com - January 8 at 3:36 PM |
| TransEnterix's Piggy Bank Gets Fatter, but Are Shares Finally a Buy?
finance.yahoo.com - December 31 at 8:56 AM |
| Transenterix Inc (TRXC) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - December 28 at 2:09 AM |
| Transenterix Inc (TRXC) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - December 19 at 3:52 PM |
| Transenterix (TRXC) Earns "Hold" Rating from BTIG Research
www.americanbankingnews.com - December 19 at 1:18 PM |
| TransEnterix & GBIL Ink Deal to Commercialize SurgiBot System
finance.yahoo.com - December 19 at 10:47 AM |
| ETFs with exposure to TransEnterix, Inc. : December 18, 2017
finance.yahoo.com - December 18 at 5:45 PM |
| This News Caused TransEnterix's Stock to Spike
finance.yahoo.com - December 18 at 3:30 PM |
| TransEnterix (TRXC) Enters Global SurgiBot System Agreement with GBIL
www.streetinsider.com - December 18 at 11:12 AM |
| Transenterix Inc (TRXC) Unleashes Deal to Commercialize SurgiBot System
finance.yahoo.com - December 18 at 11:12 AM |
 | TransEnterix announces global SurgiBot System agreement; shares ahead 13% premarket - Seeking Alpha
seekingalpha.com - December 18 at 9:12 AM |
| Transenterix Inc (TRXC) Short Interest Up 7.4% in November
www.americanbankingnews.com - December 11 at 8:36 PM |
| 7 ‘Strong Buy’ Disruptive Stocks You Should Track Now
finance.yahoo.com - December 8 at 3:30 PM |
| ETFs with exposure to TransEnterix, Inc. : December 8, 2017
finance.yahoo.com - December 8 at 3:30 PM |
| Here's Why TransEnterix Inc. Stock Tanked 22% in December
www.fool.com - December 7 at 4:22 PM |
| Here's Why TransEnterix Inc. Stock Tanked 22% in December
finance.yahoo.com - December 7 at 3:35 PM |
| TransEnterix, Senhance Marketing Underway, Expanded Indications Planned for Early 2018
finance.yahoo.com - December 7 at 9:05 AM |
| 35 Stocks Moving In Wednesday's Pre-Market Session
feeds.benzinga.com - November 29 at 8:23 AM |
| ETFs with exposure to TransEnterix, Inc. : November 27, 2017
finance.yahoo.com - November 28 at 8:31 AM |
SafeStitch Medical (NYSEAMERICAN:TRXC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
SafeStitch Medical (NYSEAMERICAN:TRXC) Income Statement, Balance Sheet and Cash Flow Statement
SafeStitch Medical (NYSEAMERICAN TRXC) Stock Chart for Sunday, April, 22, 2018
Loading chart…
